JP2005525089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525089A5 JP2005525089A5 JP2003552801A JP2003552801A JP2005525089A5 JP 2005525089 A5 JP2005525089 A5 JP 2005525089A5 JP 2003552801 A JP2003552801 A JP 2003552801A JP 2003552801 A JP2003552801 A JP 2003552801A JP 2005525089 A5 JP2005525089 A5 JP 2005525089A5
- Authority
- JP
- Japan
- Prior art keywords
- producing
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable carrier
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01000761 | 2001-12-17 | ||
| PCT/EP2002/014325 WO2003051921A1 (en) | 2001-12-17 | 2002-12-16 | Chemokine mutants acting as chemokine antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525089A JP2005525089A (ja) | 2005-08-25 |
| JP2005525089A5 true JP2005525089A5 (https=) | 2006-01-05 |
Family
ID=8176112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003552801A Pending JP2005525089A (ja) | 2001-12-17 | 2002-12-16 | ケモカイン・アンタゴニストとして作用するケモカイン突然変異体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7553483B2 (https=) |
| EP (1) | EP1458756B1 (https=) |
| JP (1) | JP2005525089A (https=) |
| AT (1) | ATE421974T1 (https=) |
| AU (1) | AU2002358144B2 (https=) |
| CA (1) | CA2468790A1 (https=) |
| DE (1) | DE60231057D1 (https=) |
| ES (1) | ES2320743T3 (https=) |
| IL (1) | IL162600A0 (https=) |
| WO (1) | WO2003051921A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2305573T3 (es) * | 2002-12-23 | 2008-11-01 | Laboratoires Serono Sa | Uso de metantes de quimiocinas cc ccl5/rantes contra transtornos del higado. |
| ATE322506T1 (de) * | 2004-01-19 | 2006-04-15 | Ares Trading Sa | Verfahren zur reinigung von in bakterien exprimierten proteinen |
| US8445442B2 (en) | 2007-04-26 | 2013-05-21 | University Of Vermont And State Agricultural College | CCL18 and CCL3 methods and compositions for detecting and treating cancer |
| US8012474B2 (en) | 2007-08-02 | 2011-09-06 | Nov Immune S.A. | Anti-RANTES antibodies |
| WO2010071610A1 (en) * | 2008-12-19 | 2010-06-24 | Agency For Science, Technology And Research (A*Star) | Severe chikungunya biomarkers |
| EP2380975A1 (de) * | 2010-04-22 | 2011-10-26 | Scil Proteins GmbH | Verfahren zur Herstellung von rekombinantem Thrombin |
| US9717777B2 (en) | 2010-05-05 | 2017-08-01 | Rappaport Family Institute For Research In The Medical Sciences | Use of CCL1 in therapy |
| US9352000B2 (en) * | 2010-05-05 | 2016-05-31 | Rappaport Family Institute For Research In The Medical Sciences | Use of CCL1 in therapy |
| EP3307330B1 (en) * | 2015-06-15 | 2021-03-10 | New York University | Method of treatment using oncolytic viruses |
| WO2017077062A1 (en) * | 2015-11-05 | 2017-05-11 | Ludwig-Maximilians-Universität München | A peptide derived from human neutrophile peptide 1 |
| KR102682118B1 (ko) | 2016-04-29 | 2024-07-08 | 주식회사유한양행 | Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도 |
| CA3233658A1 (en) | 2021-10-06 | 2023-04-13 | Ursula Gompels | Novel immune regulator |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI943024L (fi) | 1991-12-23 | 1994-06-22 | British Bio Technology | Kantasoluja estävät proteiinit |
| FI972433A0 (fi) * | 1994-12-08 | 1997-06-06 | Glaxo Group Ltd | Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia |
| AU5137698A (en) | 1996-12-05 | 1998-06-29 | Kyowa Hakko Kogyo Co. Ltd. | Novel dna, novel protein, and novel antibody |
| AU5383498A (en) * | 1996-12-05 | 1998-06-29 | Human Genome Sciences, Inc. | Human chemokine beta-13 |
| EP0906954A1 (en) | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
| DK1431391T3 (da) | 1997-12-23 | 2005-12-19 | San Raffaele Centro Fond | RANTES-mutanter og terapeutiske anvendelser heraf |
| JPH11243960A (ja) * | 1998-03-06 | 1999-09-14 | Shionogi & Co Ltd | ヒトｃｃ型ケモカインエオタキシン３ |
| ES2205849T3 (es) * | 1998-07-22 | 2004-05-01 | Osprey Pharmaceuticals Limited | Conjugados para tratar alteraciones inflamatorias y asociadas con daños tisulares. |
| AU5617900A (en) * | 1999-06-17 | 2001-01-09 | Robert C. Gallo | Chimeric chemokine-antigen polypeptides and uses therefor |
| EP2206720A1 (en) | 2000-04-12 | 2010-07-14 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| UA77950C2 (en) | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
-
2002
- 2002-12-16 US US10/499,100 patent/US7553483B2/en not_active Expired - Fee Related
- 2002-12-16 AU AU2002358144A patent/AU2002358144B2/en not_active Ceased
- 2002-12-16 IL IL16260002A patent/IL162600A0/xx unknown
- 2002-12-16 AT AT02791832T patent/ATE421974T1/de not_active IP Right Cessation
- 2002-12-16 JP JP2003552801A patent/JP2005525089A/ja active Pending
- 2002-12-16 DE DE60231057T patent/DE60231057D1/de not_active Expired - Lifetime
- 2002-12-16 EP EP02791832A patent/EP1458756B1/en not_active Expired - Lifetime
- 2002-12-16 ES ES02791832T patent/ES2320743T3/es not_active Expired - Lifetime
- 2002-12-16 CA CA002468790A patent/CA2468790A1/en not_active Abandoned
- 2002-12-16 WO PCT/EP2002/014325 patent/WO2003051921A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50102597D1 (de) | Arzneimittel gegen virale erkrankungen | |
| JP2003503454A5 (https=) | ||
| JP2005525089A5 (https=) | ||
| JP2006503588A5 (https=) | ||
| JP2002506648A5 (https=) | ||
| JP2002532112A5 (https=) | ||
| JP2005526147A5 (https=) | ||
| JP2004532810A5 (https=) | ||
| JP2004523498A5 (https=) | ||
| JP2004529078A5 (https=) | ||
| JP2004538039A5 (https=) | ||
| JP2004525194A5 (https=) | ||
| IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
| JP2005518413A5 (https=) | ||
| JP2005515404A5 (https=) | ||
| JP2006006329A5 (https=) | ||
| JP2005538045A5 (https=) | ||
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| JP2005509503A5 (https=) | ||
| JP2004529205A5 (https=) | ||
| JPH10237071A5 (https=) | ||
| JP2000031418A5 (https=) | ||
| JP2006527741A5 (https=) | ||
| JP2002277470A5 (https=) | ||
| JP2006501334A5 (https=) |